<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136158">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01888380</url>
  </required_header>
  <id_info>
    <org_study_id>Paediatric virtopsy</org_study_id>
    <nct_id>NCT01888380</nct_id>
  </id_info>
  <brief_title>The Paediatric Virtual Autopsy Trial; Minimally Invasive, Imaging Guided Virtual Autopsy Compared to Conventional Autopsy</brief_title>
  <official_title>Post-mortem Cross-sectional Imaging With Guided Biopsy; A Comparative Study With Conventional Autopsy in Foetuses, Neonates, Infants and Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <authority>Switzerland: Swissmedic</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      In light of declining autopsy rates around the world, post-mortem MR imaging is a promising
      alternative to conventional autopsy in the investigation of infant death. A major drawback
      of this non-invasive autopsy approach is the fact that histopathological and microbiological
      examination of the tissue is not possible. The objective of this prospective study is to
      compare the performance of minimally invasive, virtual autopsy, including CT-guided biopsy,
      with conventional autopsy procedures in a paediatric population.

      Foetuses, newborns, infants and children that are referred for autopsy at three different
      institutions associated with the University of Zurich will be eligible for recruitment. All
      bodies will be examined with a commercial CT and a 3 Tesla MRI scanner, and investigators
      will be blinded to the results of conventional autopsy. After cross-sectional imaging,
      CT-guided tissue sampling will be performed by a multifunctional robotic system (Virtobot)
      allowing for automated post-mortem biopsies. Virtual autopsy results will be classified with
      regards to the likely final diagnosis and major pathological findings and compared to the
      results of conventional autopsy, which remains the diagnostic gold standard. This
      interdisciplinary study will determine whether virtual autopsy will narrow the gap in
      information between non-invasive and traditional autopsy procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Percentage of cases for which virtual autopsy correctly identifies the cause of death and/or major pathological lesions</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The diagnoses established in both ways by the two independent teams will be compared, the autopsy results being the gold standard. The primary outcome will be the percentage of cases for which virtual autopsy correctly identifies the diagnostic category.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical indication</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of false positive and false negative results of virtual autopsy will be calculated for each organ system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MR Protocol</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>To optimize a protocol for MR imaging examinations in deceased foetuses, neonates, infants and children</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the ante-mortem diagnosis</measure>
    <time_frame>8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The proportion of cases, for which virtual autopsy leaded to a change in ante-mortem diagnosis, will be reported.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stillbirth</condition>
  <condition>Newborn Death</condition>
  <condition>Sudden Infant Death</condition>
  <arm_group>
    <arm_group_label>Foetuses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Still birth and termination of pregnancies</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Newborns</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Who died of natural- and non-natural cause</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Children and adolescents</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Who died of natural- and non-natural cause</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimally invasive, virtual autopsy</intervention_name>
    <arm_group_label>Foetuses</arm_group_label>
    <arm_group_label>Newborns</arm_group_label>
    <arm_group_label>Children and adolescents</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional autopsy</intervention_name>
    <arm_group_label>Foetuses</arm_group_label>
    <arm_group_label>Newborns</arm_group_label>
    <arm_group_label>Children and adolescents</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Stillborn infants ≥ 16 0/7 weeks of gestational age (GA)

          -  Live born infants ≥ 16 0/7 weeks GA until adolescents up to 16 years of age, who died
             of natural- and non-natural cause (trauma, homicide, suicide and intoxication).

        Exclusion criteria:

          -  Deceased infants who are donors of organs

          -  Lack of parental consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Ulrich Bucher, MD, Prof</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Zurich, Division of Neonatology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph Rüegger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Neonatology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christoph Rüegger, MD</last_name>
    <phone>+41 44 255 16 08</phone>
    <email>christoph.rueegger@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich, Division of Neonatology</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Rüegger, MD</last_name>
      <email>christoph.rueegger@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Christoph Rüegger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Frey, MD, Prof</last_name>
      <email>bernhard.frey@kispi.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Bernhard Frey, MD, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Division of obstetrics, University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonhard Schäffer, MD</last_name>
      <email>leonhard.schaeffer@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Leonhard Schäffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zurich Institute for Forensic Medicine</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Bartsch, MD</last_name>
      <email>christine.bartsch@irm.uzh.ch</email>
    </contact>
    <investigator>
      <last_name>Christine Bartsch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>June 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autopsy</keyword>
  <keyword>Minimally invasive</keyword>
  <keyword>Foetuses</keyword>
  <keyword>Newborns</keyword>
  <keyword>Children</keyword>
  <keyword>Adolescents</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Death</mesh_term>
    <mesh_term>Sudden Infant Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
